Hillsdale Investment Management Inc. I Teos Therapeutics, Inc. Transaction History

Hillsdale Investment Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$16.57 - $35.1 $864,954 - $1.83 Million	52,200 Added 35.88%	197,700 $4.07 Million
Q1 2022 Apr 28, 2022	SELL	$31.92 - $47.45 $31,920 - $47,450	-1,000 Reduced 0.68%	145,500 $4.68 Million
Q4 2021 Feb 07, 2022	BUY	$26.23 - $47.86 $3.84 Million - $7.01 Million	146,500 New	146,500 $6.82 Million

169

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $285M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.